2,3-dinor, 6-keto-PGF1alpha

2,3-dinor, 6-keto-pgf1alpha is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 782 references associated with 2,3-dinor, 6-keto-PGF1alpha in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

Here are additional resources we collected from PubChem and MeSH for 2,3-dinor, 6-keto-PGF1alpha

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 2,3-dinor, 6-keto-PGF1alpha

MeSH term MeSH ID Detail
Pulmonary Heart Disease D011660 2 associated lipids
Tibial Fractures D013978 4 associated lipids
Diseases in Twins D004200 4 associated lipids
Bartter Syndrome D001477 5 associated lipids
Carotid Artery Thrombosis D002341 7 associated lipids
Aortic Aneurysm D001014 8 associated lipids
Respiratory Syncytial Virus Infections D018357 10 associated lipids
Cerebral Hemorrhage D002543 13 associated lipids
Angina, Unstable D000789 14 associated lipids
Alcoholic Intoxication D000435 15 associated lipids
Down Syndrome D004314 18 associated lipids
Pregnancy Complications D011248 19 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Ascites D001201 25 associated lipids
Cerebrovascular Disorders D002561 25 associated lipids
Endometriosis D004715 29 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Thrombosis D013927 49 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Per page 10 20 50 | Total 25

NCBI Entrez Crosslinks

All references with 2,3-dinor, 6-keto-PGF1alpha

Download all related citations
Per page 10 20 50 100 | Total 191
Authors Title Published Journal PubMed Link
Fischer C and Meese CO Simultaneous determination of 6-oxo-prostaglandin F1 alpha and 2,3-dinor-6-oxo-prostaglandin F1 alpha in biological fluids by stable isotope dilution and negative ion chemical ionization mass spectrometry. 1985 Biomed. Mass Spectrom. pmid:2931130
Roy L et al. Endogenous biosynthesis of prostacyclin during cardiac catheterization and angiography in man. 1985 Circulation pmid:3882264
Watson ML et al. Urinary kallikrein and systemic prostacyclin synthesis during sodium chloride infusion in normal man. 1985 Clin. Sci. pmid:3884237
Martineau A et al. Defective synthesis of vasodilator prostaglandins in the spontaneously hypertensive rat. 1984 Mar-Apr Hypertension pmid:6373595
Fitzgerald DJ et al. The effects of organic nitrates on prostacyclin biosynthesis and platelet function in humans. 1984 Circulation pmid:6428771
Liggins GC et al. Prostacyclin and maternal lupus anticoagulant. 1984 Lancet pmid:6140483
FitzGerald GA et al. Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation. 1984 N. Engl. J. Med. pmid:6231483
Vesterqvist O and Gréen K Development of a GC-MS method for quantitation of 2,3-dinor-6-keto-PGF1 alpha and determination of the urinary excretion rates in healthy humans under normal conditions and following drugs. 1984 Prostaglandins pmid:6548317
Oates JA et al. Comparison of the effects of selective inhibition of thromboxane synthase with those of inhibition of the cyclooxygenase enzyme in man. 1984 Trans. Am. Clin. Climatol. Assoc. pmid:6433527
Watson ML et al. Prostaglandins and kallikrein during volume expansion in normal man. 1984 Contrib Nephrol pmid:6570094